drugset / Trial / NCT03709927

4-way Crossover QT Evaluation in Healthy Subjects

NCT03709927

Phase 1 Completed 41 enrolled Nabriva Therapeutics AG
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to evaluate if ZTI-01 (fosfomycin for injection), an investigational drug being developed to treat people with complicated urinary tract and kidney infections, has any effect on the electrical activity of the heart.

Timeline

Start
2018-01-11
Primary completion
2018-04-12
Completion
2018-08-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Fosfomycin Small molecule 6 g Intravenous
Subject Fosfomycin Small molecule 12 g Intravenous
Comparator Moxifloxacin Small molecule 400 mg Oral

Indications

No indication recorded.